APP Activators

Common APP Activators include, but are not limited to Retinoic Acid, all trans CAS 302-79-4, Lipopolysaccharide, E. coli O55:B5 CAS 93572-42-0, Dexamethasone CAS 50-02-2, Ob (hBA-147) CAS 177404-21-6 and PMA CAS 16561-29-8.

Amyloid Precursor Protein (APP) is a transmembrane protein expressed in many tissues and concentrated in the synapses of neurons. It's notable for its role in Alzheimer's disease, as its cleavage can lead to the formation of amyloid-beta, a primary component of amyloid plaques. Understanding the compounds that can induce its expression is vital. APP (Amyloid Precursor Protein) Activators are a class of compounds that impact the processing and regulation of the amyloid precursor protein. APP is a transmembrane protein predominantly found in neuronal cells and has garnered significant attention due to its association with Alzheimer's disease (AD). The proteolytic processing of APP can lead to the formation of amyloid-β (Aβ) peptides, which are a hallmark of AD pathology. APP processing is a complex series of enzymatic cleavages involving α-secretase, β-secretase (BACE-1), and γ-secretase, ultimately leading to the generation of various APP fragments, including Aβ peptides. Activators of APP can modulate these processing pathways, influencing the production of Aβ peptides and other APP metabolites.

Research into APP Activators is crucial for understanding the molecular mechanisms underlying Alzheimer's disease and related neurodegenerative disorders. These compounds help shed light on the intricate balance between the processing pathways of APP, especially the β-secretase and γ-secretase cleavages, and their role in the accumulation of Aβ peptides, which form plaques in the brain. By influencing APP processing, these activators offer insights into strategies to mitigate Aβ accumulation and neurodegeneration.